Symbol: |
CCDC122
|
Description: |
coiled-coil domain containing 122 [Source:HGNC Symbol;Acc:26478]
|
Location: |
Chr13:44398045-44453864[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:129
Gene |
Compound |
Gen_sig |
Exp_pattern |
CCDC122 |
NSC 116532 |
0.031 |
Up |
CCDC122 |
NSC 11865 |
0.043 |
Up |
CCDC122 |
Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- |
0.048 |
Up |
CCDC122 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.006 |
Up |
CCDC122 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.018 |
Up |
CCDC122 |
Benzamide, N-[2-(diethylamino)ethyl]-4-methyl-2-nitro- 3-(phenylmethoxy)- |
0.028 |
Up |
CCDC122 |
NSC 166382 |
0.046 |
Up |
CCDC122 |
NSC 168197 |
0.038 |
Up |
CCDC122 |
Bromocriptine methanesulfonate |
0.026 |
Up |
CCDC122 |
Pimozide |
0.008 |
Up |
CCDC122 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.015 |
Up |
CCDC122 |
NSC 17753 |
0.033 |
Up |
CCDC122 |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.039 |
Up |
CCDC122 |
Buclizine Hydrochloride |
0.004 |
Up |
CCDC122 |
NSC 26669 |
0.01 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:19
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev]  Next Last 
|